Dapagliflozin transforms into heart failure drug

MDedge Cardiocast

Contenuto fornito da MDedge. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da MDedge o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.

4+ y ago 9:40

MP3•Pagina principale dell'episodio

DAPA-HF results transform dapagliflozin from antidiabetic to heart failure drug

Proof that dapagliflozin significantly helped heart failure patients without diabetes recategorizes the drug as a major agent for treating heart failure.

New hypertension cases halved with community-wide salt substitution

Social marketing principles achieved near-universal salt replacement, village by village, in rural Peru.

Ticagrelor: Modest benefit, bigger bleed risk in diabetes plus stable CAD

Patients with prior PCI fared a bit better and may be a target population for long-term DAPT therapy.

In PAD, dropping statins ups death risk 43%

Statin adherence saves lives in peripheral arterial disease.

87 episodi

#Science #Medicine #Cardiology #Cardiologynews #Biology #Fitness #MDedge #Cardiologists